Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 385

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Open access
Luoma, Adrienne M., Suo, Shengbao, Wang, Yifan, Gunasti, Lauren, Porter, Caroline B.M., Nabilsi, Nancy, Tadros, Jenny, Ferretti, Andrew P., Liao, Sida, Gurer, Cagan, Chen, Yu-Hui, Criscitiello, Shana, Ricker, Cora A., Dionne, Danielle, Rozenblatt-Rosen, Orit, Uppaluri, Ravindra, Haddad, Robert I., Ashenberg, Orr, Regev, Aviv, Van Allen, Eliezer M., MacBeath, Gavin, Schoenfeld, Jonathan D., Wucherpfennig, Kai W.·2022·Cell

Abstract

Summary Neoadjuvant immune checkpoint blockade has shown promising clinical activity. Here, we characterized early kinetics in tumor-infiltrating and circulating immune cells in oral cancer patients treated with neoadjuvant anti-PD-1 or anti-PD-1/CTLA-4 in a clinical trial (NCT02919683). Tumor-infiltrating CD8 T cells that clonally expanded during immunotherapy expressed elevated tissue-resident memory and cytotoxicity programs, which were already active prior to therapy, supporting the capacity for rapid response. Systematic target discovery revealed that treatment-expanded tumor T cell clones in responding patients recognized several self-antigens, including the cancer-specific antigen MAGEA1. Treatment also induced a systemic immune response characterized by expansion of activated T cells enriched for tumor-infiltrating T cell clonotypes, including both pre-existing and emergent clonotypes undetectable prior to therapy. The frequency of activated blood CD8 T cells, notably pretreatment PD-1-positive KLRG1-negative T cells, was strongly associated with intra-tumoral pathological response. These results demonstrate how neoadjuvant checkpoint blockade induces local and systemic tumor immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2022.06.018

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 87 references

Cited by

See all 385

Metadata

Authors
Luoma, A. M., Suo, S., Wang, Y., Gunasti, L., Porter, C. B. M., Nabilsi, N., Tadros, J., Ferretti, A. P., Liao, S., Gurer, C., Chen, Y.-H., Criscitiello, S., Ricker, C. A., Dionne, D., Rozenblatt-Rosen, O., Uppaluri, R., Haddad, R. I., Ashenberg, O., Regev, A., Van Allen, E. M., MacBeath, G., Schoenfeld, J. D., & Wucherpfennig, K. W.
Venue
Cell
Publisher
Elsevier BV
Published
2022-08
Volume
185
Issue
16
Pages
2918-2935.e29
ISSN
0092-8674 (ISSN-L)
OpenAlex
W4284690107
Cited by
385
References
87
FWCI
28.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. https://app.cochat.ai/papers/10.1016/j.cell.2022.06.018
The paper
Luoma, A. M., Suo, S., Wang, Y., Gunasti, L., Porter, C. B. M., Nabilsi, N., Tadros, J., Ferretti, A. P., Liao, S., Gurer, C., Chen, Y.-H., Criscitiello, S., Ricker, C. A., Dionne, D., Rozenblatt-Rosen, O., Uppaluri, R., Haddad, R. I., Ashenberg, O., Regev, A., . . . Wucherpfennig, K. W. (2022). Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell. https://doi.org/10.1016/j.cell.2022.06.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.